Vincenzo Bagnardi Selected Research

Vincenzo Bagnardi Research Topics

Disease

45	Breast Neoplasms (Breast Cancer) 04/2022 - 10/2008
44	Neoplasms (Cancer) 06/2022 - 05/2005
11	Neoplasm Metastasis (Metastasis) 06/2022 - 06/2012
7	Triple Negative Breast Neoplasms 01/2022 - 08/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 01/2018
3	Melanoma (Melanoma, Malignant) 02/2022 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 09/2010
3	Alopecia (Baldness) 12/2021 - 01/2019
3	Lung Neoplasms (Lung Cancer) 10/2020 - 02/2009
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2017 - 11/2012
3	Disease Progression 12/2016 - 06/2012
2	Colorectal Neoplasms (Colorectal Cancer) 04/2022 - 11/2017
2	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 01/2020
2	Rectal Neoplasms (Rectal Cancer) 01/2021 - 10/2019
2	COVID-19 01/2021 - 01/2021
2	Brain Death (Brain Dead) 01/2021 - 11/2018
2	Obesity 01/2020 - 11/2013
2	Syncope (Fainting) 01/2020 - 03/2016
2	Leukemia 01/2020 - 09/2010
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 08/2007
2	Heart Arrest (Cardiac Arrest) 12/2017 - 03/2016
2	Lymphatic Metastasis 08/2014 - 10/2010
2	Hypertension (High Blood Pressure) 03/2009 - 05/2007
2	Cardiac Arrhythmias (Arrythmia) 11/2006 - 01/2005
1	Hemangiosarcoma (Angiosarcoma) 01/2022
1	Body Weight (Weight, Body) 12/2021
1	Insulin Resistance 12/2021
1	Residual Neoplasm 10/2021
1	Lobular Carcinoma 10/2021
1	Lymphoma (Lymphomas) 01/2021
1	Heart Failure 01/2021
1	Microsatellite Instability 01/2021
1	Ovarian Epithelial Carcinoma 02/2020

Drug/Important Bio-Agent (IBA)

12	Hormones (Hormone)IBA 07/2018 - 07/2009
11	Biological ProductsIBA 02/2022 - 03/2009
9	Estrogen ReceptorsIBA 02/2020 - 08/2010
7	Progesterone Receptors (Progesterone Receptor)IBA 02/2020 - 08/2010
7	Bevacizumab (Avastin)FDA Link 01/2018 - 10/2008
6	Phenobarbital (Luminal)FDA Link 12/2021 - 02/2014
6	Capecitabine (Xeloda)FDA Link 01/2020 - 10/2008
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2018 - 10/2008
5	ErbB Receptors (EGF Receptor)IBA 12/2020 - 08/2010
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 12/2009
4	AnthracyclinesIBA 12/2021 - 03/2009
4	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2009
4	Trastuzumab (Herceptin)FDA Link 01/2018 - 04/2010
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 03/2009
3	Vinorelbine (Navelbine)FDA LinkGeneric 07/2018 - 04/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 03/2009
3	Letrozole (Femara)FDA LinkGeneric 10/2015 - 04/2010
3	human ERBB2 proteinIBA 10/2014 - 11/2013
2	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2018
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2021 - 10/2010
2	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2020
2	ParaffinIBA 01/2020 - 08/2014
2	Formaldehyde (Formol)FDA Link 01/2020 - 08/2014
2	Progesterone FDA LinkGeneric 01/2018 - 08/2015
2	Epirubicin (Ellence)FDA LinkGeneric 08/2015 - 03/2009
2	Pharmaceutical PreparationsIBA 08/2014 - 01/2005
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2012 - 06/2012
2	Hemoglobins (Hemoglobin)IBA 06/2012 - 09/2010
2	SteroidsIBA 08/2010 - 07/2009
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 06/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2022
1	Cadherins (E-Cadherin)IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	liposomal doxorubicin (Doxil)FDA Link 12/2021
1	Insulin (Novolin)FDA Link 12/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	A-factor (Streptomyces)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 12/2020
1	Angiogenesis InhibitorsIBA 12/2020
1	AntibodiesIBA 02/2020
1	AntigensIBA 02/2020
1	VaccinesIBA 02/2020

Therapy/Procedure

25	Therapeutics 10/2021 - 05/2007
24	Drug Therapy (Chemotherapy) 06/2022 - 10/2008
9	Adjuvant Chemotherapy 01/2022 - 02/2014
7	Neoadjuvant Therapy 12/2021 - 10/2010
6	Immunotherapy 02/2022 - 01/2018
5	Mastectomy (Mammectomy) 03/2022 - 11/2014
4	Liver Transplantation 01/2021 - 11/2018
3	Radiotherapy 04/2022 - 12/2019
3	Segmental Mastectomy (Lumpectomy) 01/2022 - 01/2016
2	Mediterranean Diet 12/2021 - 10/2020
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 10/2021 - 04/2020
2	Extracorporeal Membrane Oxygenation 01/2021 - 11/2018
2	Mammaplasty (Breast Reconstruction) 10/2015 - 11/2014
1	Salvage Therapy 06/2022
1	Biological Therapy 04/2022
1	Gastrectomy 01/2022
1	High-Protein Diet 12/2021
1	Re-Irradiation 12/2021
1	Lymph Node Excision (Lymph Node Dissection) 10/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Heart-Assist Devices 01/2021
1	Aftercare (After-Treatment) 10/2020
1	Colostomy 04/2020